by Piero Cingari | Jun 12, 2026 | General
Elon Musk‘s rocket company SpaceX (NASDAQ:SPCX) just completed the largest stock market debut in history, and demand ran so heavy that bankers turned away billions in orders. Yet, some investors wanted no part of it. SpaceX priced its initial public offering at $135 a...
by Kaustubh Bagalkote | Jun 12, 2026 | General
Virgin Galactic Holdings Inc. (NYSE:SPCE) shares are moving lower on Friday. The space tourism pioneer is facing downward pressure from a combination of classic profit-taking and a fresh regulatory filing detailing equity dilution. The Nasdaq is up 0.13% while the...
by Parshwa Turakhiya | Jun 12, 2026 | General
Bitwise Head of Research Europe André Dragosch said Friday that Bitcoin (CRYPTO: BTC) faces up to 20% further downside from current levels, with the long-term holder cost basis near $48,000 as his max pain scenario. Three Support Levels Stack Between $48,000 and...
by Lekha Gupta | Jun 12, 2026 | General
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ:BYAH) disclosed a strategic partnership with Star Plus Action, aiming to innovate within the healthcare and skincare sectors. This collaboration boosted the stock price as investors anticipate accelerated...
by Vandana Singh | Jun 12, 2026 | General
Silence Therapeutics Plc (NASDAQ:SLN) shares are up during Friday’s session. On Thursday, the company highlighted follow-up data from its Phase 1 SANRECO study of divesiran. SLN Stock Catalyst: SANRECO Phase 1 Follow-Up Data Recent analyses from the Phase 1 SANRECO...
by Vandana Singh | Jun 12, 2026 | General
MBX Biosciences Inc. (NASDAQ:MBX) on Thursday reported full results from its 12-week Avail Phase 2 trial and new one-year data from an ongoing open-label extension study of once-weekly canvuparatide in adults with chronic hypoparathyroidism. Hypoparathyroidism is a...
Recent Comments